The Vittamed 205 offers non-invasive ICP measurement for conditions such as traumatic brain injury, concussion, hydrocephalus, stroke, brain tumors, and other neurological diseases.
Using Doppler ultrasound and the ophthalmic artery as a natural ICP sensor, Vittamed 205 measures absolute ICP value in mmHg.
Clinically validated in prospective clinical trials, the ICP meter provides accurate and precise measurements and does not require an individual patient specific calibration.
The Vittamed 505 allows clinicians to non-invasively monitor cerebrovascular autoregulational and evaluate cerebral blood flow after traumatic brain injury, in stroke, during cardiac surgery, in the critical care unit and in the outpatient clinic.
Vilnius University, Lithuania, Neurology and Neurosurgery Clinic Neurovascular Center head Saulius Rocka said: "We have been very encouraged with the results of non-invasive diagnostic devices.
"This platform gives us, neurosurgeons, the possibility to understand what is happening in the brain without invasion and any increase in risk for patient.
"We can also, for the first time, easily monitor conscious individuals and outpatients. Vittamed’s instruments enable clinicians to obtain safer, faster, and accurate measurements of absolute intracranial pressure values."
The technology was originally developed at the Kaunas University of Technology’s Health Telematics Science Center and is clinically validated in prospective multicenter clinical trials in the EU and the US.
